Stock Price
332.20
Daily Change
-0.80 -0.24%
Monthly
-21.63%
Yearly
-29.83%
Q1 Forecast
339.87


Peers Price Chg Day Year Date
Adecco 28.36 1.52 5.66% -20.49% Mar/14
Ashtead 4,345.00 0.0001 0% -16.25% Mar/15
Amadeus IT 69.60 1.38 2.02% 21.04% Mar/14
Babcock International 752.50 31.00 4.30% 47.26% Mar/14
Bunzl 2,942.00 -2.00 -0.07% -2.06% Mar/15
Bureau Veritas 27.78 -0.22 -0.79% 4.44% Mar/14
Capita 13.88 0.30 2.21% 2.44% Mar/14
DCC 5,225.00 20.00 0.38% -8.81% Mar/14
Eurofins Scientific SE 49.21 -1.19 -2.36% -12.28% Mar/14
Experian 3,544.00 -0.0001 0% 6.14% Mar/15
Ferguson 12,310.00 400.00 3.36% -24.20% Mar/14
IMCD 131.35 1.70 1.31% -18.03% Mar/14
ISS 164.90 1.70 1.04% 35.05% Mar/14
Intertek 4,896.00 10.00 0.20% 1.03% Mar/15
Lassila & Tikanoja 8.88 0.04 0.45% -1.77% Mar/14
Randstad 42.62 0.09 0.21% -15.44% Mar/15
Securitas 149.20 1.65 1.12% 38.60% Mar/14
SGS 87.60 -0.92 -1.04% 3.72% Mar/14
Serco 158.50 0.10 0.06% -14.32% Mar/14
Teleperformance SE 95.90 -1.84 -1.88% 10.03% Mar/14

Indexes Price Day Year Date
GB100 8632 89.77 1.05% 11.71% Mar/14
EU600 547 6.16 1.14% 8.28% Mar/14

Rentokil Initial traded at 332.20 this Saturday March 15th, decreasing 0.80 or 0.24 percent since the previous trading session. Looking back, over the last four weeks, Rentokil Initial lost 21.63 percent. Over the last 12 months, its price fell by 29.83 percent. Looking ahead, we forecast Rentokil Initial to be priced at 339.87 by the end of this quarter and at 335.91 in one year, according to Trading Economics global macro models projections and analysts expectations.